Furthermore, we found that BMP - 6 had an antiproliferative effect both in naive ( CD19 + CD27 -) and memory B cells ( CD19 + CD27 +) stimulated with anti - IgM alone or the combined action of anti - IgM and CD40L.	"BMP - 6	27	34	Protein"	"CD19	83	87	Protein"	"CD27	90	94	Protein"	"CD19	119	123	Protein"	"CD27	126	130	Protein"	"CD40L	208	213	Protein"	"[{""token"": ""BMP - 6"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""CD19"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""CD27"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""CD19"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Protein""}, {""token"": ""CD27"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""CD40L"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Protein""}]"
Naive ( CD19 + CD27 -) and memory ( CD19 + CD27 +) B cells were isolated from peripheral blood by cell sorting of immunobead - isolated CD19 + B cells [ 15], and tested for their capacity to proliferate in the presence of BMP - 6.	"CD19	8	12	Protein"	"CD27	15	19	Protein"	"CD19	36	40	Protein"	"CD27	43	47	Protein"	"CD19	136	140	Protein"	"BMP - 6	222	229	Protein"	"[{""token"": ""CD19"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""CD27"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""CD19"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""CD27"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CD19"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Protein""}, {""token"": ""BMP - 6"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Protein""}]"
In contrast to the upregulation of BMP - 6 transcript in B cells, we were not able to detect BMP - 6 transcripts in human peripheral blood CD4 + or CD8 + T cells ( resting or stimulated with anti - CD3 and anti - CD28; data not shown), consistent with the findings in T cell lines [ 20] and T cells in mice [ 43].	"BMP - 6	35	42	Protein"	"BMP - 6	93	100	Protein"	"CD4	139	142	Protein"	"CD8	148	151	Protein"	"CD3	198	201	Protein"	"CD28	213	217	Protein"	"[{""token"": ""BMP - 6"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""BMP - 6"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""CD8"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Protein""}]"
pBS - kRSPA - TatHIV - 1 ( NL4 - 3) was constructed by amplifying the two exons of Tat via PCR reaction using the molecular clone pNL4 - 3 as template and the following primer sets: exon1, 5UXho1HIV - Tat1Plus ( 5 ' - GCATGCTCGAGATGGAGCCAGTAGATCCTAG - 3 ') and HIV - Tat1Minus ( 5 ' - TGCTTTGATAGAGAAGCTTGATG - 3 '); exon2, 15FHIV - Tat2Plus ( 5 ' - TTCTCTATCAAAGCAACCCACCTCCCAATCCCG - 3 ') and 5USpe1HIV - Tat2Minus ( 5 ' - GACGTACTAGTCTATTCCTTCGGGCCTGTC - 3 ').	"TatHIV	14	20	Protein"	"Tat	83	86	Protein"	"Tat1Plus	201	209	Protein"	"Tat1Minus	267	276	Protein"	"Tat2Plus	333	341	Protein"	"Tat2Minus	407	416	Protein"	"[{""token"": ""TatHIV"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""Tat1Plus"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Protein""}, {""token"": ""Tat1Minus"", ""start_span"": 267, ""end_span"": 276, ""type"": ""Protein""}, {""token"": ""Tat2Plus"", ""start_span"": 333, ""end_span"": 341, ""type"": ""Protein""}, {""token"": ""Tat2Minus"", ""start_span"": 407, ""end_span"": 416, ""type"": ""Protein""}]"
( A) Nuclear extracts of A3. 01 T cells were incubated with a 32P - labeled commercial Sp1 oligonucleotide probe ( Sp1cons) or labeled probes homologous to the unmodified or mutated E2 region ( see Figure 1) of the A3G promoter ( APO - Sp1 / 3 and APO - Sp1 / 3mut).	"Sp1	87	90	Protein"	"A3G	215	218	Protein"	"Sp1	236	239	Protein"	"3	242	243	Protein"	"Sp1	254	257	Protein"	"3mut	260	264	Protein"	"[{""token"": ""Sp1"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""A3G"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 242, ""end_span"": 243, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 254, ""end_span"": 257, ""type"": ""Protein""}, {""token"": ""3mut"", ""start_span"": 260, ""end_span"": 264, ""type"": ""Protein""}]"
To investigate whether FOXP3 can be expressed by any T cell subset or if expression is restricted to a distinct lineage, FOXP3 mRNA expression was analyzed in freshly isolated T cells such as CD25 - depleted CD4 + cells, CD45RA + naive or CD45RO + memory T cells ( Figure 1A), as well as T cells driven in vitro toward Th1, Th2, or iTreg phenotypes ( Figure 1B; phenotype on Figure S1).	"FOXP3	23	28	Protein"	"FOXP3	121	126	Protein"	"CD25	192	196	Protein"	"CD4	208	211	Protein"	"CD45RA	221	227	Protein"	"CD45RO	239	245	Protein"	"[{""token"": ""FOXP3"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 221, ""end_span"": 227, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Protein""}]"
Therefore, we analyzed the expression of FOXP3 and GATA3 during the differentiation of naive CD4 T cells into Th0 ( neutral, anti - IL - 4, anti - IFN - gamma, and anti IL - 12), Th2, and iTreg phenotypes.	"FOXP3	41	46	Protein"	"GATA3	51	56	Protein"	"CD4	93	96	Protein"	"IL - 4	132	138	Protein"	"IFN - gamma	147	158	Protein"	"IL - 12	169	176	Protein"	"[{""token"": ""FOXP3"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""IL - 12"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Protein""}]"
Human CD4 + CD45RA + T cells were activated with plate - bound anti - CD3 / CD28 in the presence of TGF - beta and / or IL - 4 and harvested after 5 d.	"CD4	6	9	Protein"	"CD45RA	12	18	Protein"	"CD3	70	73	Protein"	"CD28	76	80	Protein"	"TGF - beta	100	110	Protein"	"IL - 4	120	126	Protein"	"[{""token"": ""CD4"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Protein""}]"
The expression kinetic of naive T cells exposed to IL - 4 and TGF - beta demonstrated that GATA3 and FOXP3 are initially found in separate populations ( day 2), but transiently co - express both factors ( days 4 - 8), before establishing separate populations at the end of the differentiation process ( day 10; Figure 6C), suggesting that GATA3 inhibits the development of iTreg cells by repressing FOXP3.	"IL - 4	51	57	Protein"	"TGF - beta	62	72	Protein"	"GATA3	91	96	Protein"	"FOXP3	101	106	Protein"	"GATA3	339	344	Protein"	"FOXP3	399	404	Protein"	"[{""token"": ""IL - 4"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 62, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 339, ""end_span"": 344, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 399, ""end_span"": 404, ""type"": ""Protein""}]"
To investigate whether GATA3 can directly inhibit FOXP3 induction, we transduced GATA3 or a truncated GATA3 lacking the DNA - binding domain in human primary CD4 + CD45RA + T cells using a TAT - fused, recombinantly expressed GATA3.	"GATA3	23	28	Protein"	"FOXP3	50	55	Protein"	"GATA3	81	86	Protein"	"GATA3	102	107	Protein"	"CD4	158	161	Protein"	"CD45RA	164	170	Protein"	"[{""token"": ""GATA3"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Protein""}]"
In addition, we analyzed the inhibitory effect of GATA3 on FOXP3 in transgenic DO11. 10 mice, constitutively overexpressing GATA3 under the control of the CD2 locus control region ( DO11. 10xCD2 - GATA3).	"GATA3	50	55	Protein"	"FOXP3	59	64	Protein"	"GATA3	124	129	Protein"	"CD2	155	158	Protein"	"10xCD2	188	194	Protein"	"GATA3	197	202	Protein"	"[{""token"": ""GATA3"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""10xCD2"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Protein""}]"
To investigate the effect of GATA3 on iTreg, CD4 + CD62L + CD25 - cells were isolated, activated with OVA in the presence or absence of TGF - beta, and Foxp3 expression was analyzed after 4 d.	"GATA3	29	34	Protein"	"CD4	45	48	Protein"	"CD62L	51	56	Protein"	"CD25	59	63	Protein"	"TGF - beta	136	146	Protein"	"Foxp3	152	157	Protein"	"[{""token"": ""GATA3"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""CD62L"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 136, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Protein""}]"
Since IL - 13 does not effectively reduce FOXP3 and fails to induce GATA3, we hypothesized that the IL - 4 - dependent inhibition of FOXP3 could be mediated by GATA3.	"IL - 13	6	13	Protein"	"FOXP3	42	47	Protein"	"GATA3	68	73	Protein"	"IL - 4	100	106	Protein"	"FOXP3	133	138	Protein"	"GATA3	160	165	Protein"	"[{""token"": ""IL - 13"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Protein""}]"
In fact, GATA3 - inducing IL - 4 concentrations repressed TGF - beta - mediated FOXP3 expression, whereas IL - 4 as well as TGF - beta signaling were intact.	"GATA3	9	14	Protein"	"IL - 4	26	32	Protein"	"TGF - beta	58	68	Protein"	"FOXP3	80	85	Protein"	"IL - 4	106	112	Protein"	"TGF - beta	124	134	Protein"	"[{""token"": ""GATA3"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Protein""}]"
Transgenic DO11. 10 mice, expressing a T cell receptor for OVA323 - 339 peptide in the context of H - 2d, were backcrossed with mice expressing GATA - 3, driven by the human CD2 locus control region ( CD2 - GATA3) [ 22], resulting in DO11. 10xCD2 - GATA3 mice.	"GATA - 3	144	152	Protein"	"CD2	174	177	Protein"	"CD2	201	204	Protein"	"GATA3	207	212	Protein"	"10xCD2	240	246	Protein"	"GATA3	249	254	Protein"	"[{""token"": ""GATA - 3"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 207, ""end_span"": 212, ""type"": ""Protein""}, {""token"": ""10xCD2"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 249, ""end_span"": 254, ""type"": ""Protein""}]"
For cell surface marker staining, cells were incubated for 20 min at 4degreesC in staining buffer with the following antibodies: anti - CD152 - PE ( CTLA - 4; BD), anti - PD - 1 ( eBiosciences), anti - GITR ( R & D Systems), anti - CD69 ( Beckman Coulter), anti - CD103 ( DakoCytomation), anti - CD62L ( Beckman Coulter), or anti - HLA - DR ( Beckman Coulter).	"CD152	136	141	Protein"	"PD - 1	171	177	Protein"	"GITR	202	206	Protein"	"CD69	232	236	Protein"	"CD103	264	269	Protein"	"CD62L	296	301	Protein"	"[{""token"": ""CD152"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""PD - 1"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""GITR"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""CD69"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Protein""}, {""token"": ""CD103"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Protein""}, {""token"": ""CD62L"", ""start_span"": 296, ""end_span"": 301, ""type"": ""Protein""}]"
To isolate naive murine CD4 T cells from murine DO11. 10 or DO11. 10xCD2 - GATA3 T cells, cells were stained with anti - CD25 - FITC, anti - CD62L - PE, and anti - CD4 - APC prior to sorting.	"CD4	24	27	Protein"	"10xCD2	66	72	Protein"	"GATA3	75	80	Protein"	"CD25	121	125	Protein"	"CD62L	141	146	Protein"	"CD4	164	167	Protein"	"[{""token"": ""CD4"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""10xCD2"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""CD62L"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Protein""}]"
The membranes were re - probed using anti - GATA3 ( HG3 - 31; Santa Cruz Biotechnology), anti - T - bet ( 4B10, Santa Cruz Biotechnology), anti - GAPDH ( 6C5, Ambion), anti - phospho - SMAD2 ( 138D4), anti - phospho - STAT6 ( 5A4), and anti - STAT6 ( Cell Signaling Technology),	"GATA3	44	49	Protein"	"T - bet	96	103	Protein"	"GAPDH	146	151	Protein"	"SMAD2	185	190	Protein"	"STAT6	218	223	Protein"	"STAT6	243	248	Protein"	"[{""token"": ""GATA3"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""T - bet"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""GAPDH"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""SMAD2"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Protein""}]"
( A) Human CD4 + CD45RA + T cells were activated with plate - bound anti - CD3 / CD28 in the presence of TGF - beta ( 5 ng / ml) or IL - 4 ( 25 ng / ml).	"CD4	11	14	Protein"	"CD45RA	17	23	Protein"	"CD3	75	78	Protein"	"CD28	81	85	Protein"	"TGF - beta	105	115	Protein"	"IL - 4	132	138	Protein"	"[{""token"": ""CD4"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Protein""}]"
( C) CD4 + CD45RA + cells were stimulated in vitro with plate - bound anti - CD3 / CD28, TGF - beta ( 10ng / ml), and IL - 4 ( 100 ng / ml) as indicated.	"CD4	5	8	Protein"	"CD45RA	11	17	Protein"	"CD3	77	80	Protein"	"CD28	83	87	Protein"	"TGF - beta	89	99	Protein"	"IL - 4	118	124	Protein"	"[{""token"": ""CD4"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Protein""}]"
CFSE - labeled CD4 + CD45RA + cells were activated with plate - bound anti - CD3 / CD28, TGF - beta, and IL - 4, as indicated.	"CD4	15	18	Protein"	"CD45RA	21	27	Protein"	"CD3	77	80	Protein"	"CD28	83	87	Protein"	"TGF - beta	89	99	Protein"	"IL - 4	105	111	Protein"	"[{""token"": ""CD4"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Protein""}]"
( A) Human naive CD4 + CDRA + T cells were transduced with 0, 20, 100, and 500 nM of TAT - GATA3 protein, and intracellular presence of GATA3 was analyzed using FACS following anti - CD3 / CD28 activation of the cells.	"CD4	17	20	Protein"	"CDRA	23	27	Protein"	"TAT - GATA3	85	96	Protein"	"GATA3	136	141	Protein"	"CD3	183	186	Protein"	"CD28	189	193	Protein"	"[{""token"": ""CD4"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Protein""}, {""token"": ""CDRA"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""TAT - GATA3"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Protein""}]"
Using overexpression and CAT - reporter genes, Lavender and colleagues [ 33] have shown that GR reduced GATA - 3 - mediated IL - 5 and - 13 promoter activity in human CD4 + T cells.	"CAT	25	28	Protein"	"GR	93	95	Protein"	"GATA - 3	104	112	Protein"	"IL - 5	124	130	Protein"	"- 13	135	139	Protein"	"CD4	167	170	Protein"	"[{""token"": ""CAT"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""GR"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""GATA - 3"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""- 13"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Protein""}]"
Inactivation of the gene encoding RUNX cofactor core - binding factor - beta ( CBFbeta) in mice and small interfering RNA ( siRNA) - mediated suppression of RUNX1 and RUNX3 in human T cells resulted in reduced expression of Foxp3.	"RUNX	34	38	Protein"	"core - binding factor - beta	48	76	Protein"	"CBFbeta	79	86	Protein"	"RUNX1	157	162	Protein"	"RUNX3	167	172	Protein"	"Foxp3	224	229	Protein"	"[{""token"": ""RUNX"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""core - binding factor - beta"", ""start_span"": 48, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""CBFbeta"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 224, ""end_span"": 229, ""type"": ""Protein""}]"
The in vivo conversion of naive CD4 + T cells into Foxp3 + iT reg cells was significantly decreased in adoptively transferred CbfbF / F CD4 - cre naive T cells into Rag2 - / - mice.	"CD4	32	35	Protein"	"Foxp3	51	56	Protein"	"CbfbF	126	131	Protein"	"CD4	136	139	Protein"	"cre	142	145	Protein"	"Rag2	165	169	Protein"	"[{""token"": ""CD4"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""cre"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""Rag2"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Protein""}]"
It was further demonstrated that both Th1 and Th2 transcription factors T - bet and GATA3 oppose peripheral induction of Foxp3 + T reg cells in mice through STAT1 -, STAT4 -, and STAT6 - dependent pathways ( Wei et al., 2007).	"T - bet	72	79	Protein"	"GATA3	84	89	Protein"	"Foxp3	121	126	Protein"	"STAT1	157	162	Protein"	"STAT4	166	171	Protein"	"STAT6	179	184	Protein"	"[{""token"": ""T - bet"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""STAT1"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Protein""}, {""token"": ""STAT4"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Protein""}]"
Stimulation with anti - CD2 / 3 / 28 mAbs or TGF - beta alone resulted in a minimal up - regulation of RUNX1 and RUNX3 mRNA ( Fig. 1 A).	"CD2	24	27	Protein"	"3	30	31	Protein"	"28	34	36	Protein"	"TGF - beta	45	55	Protein"	"RUNX1	103	108	Protein"	"RUNX3	113	118	Protein"	"[{""token"": ""CD2"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 30, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 34, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Protein""}]"
TGF - beta induced Foxp3 in CbfbF / + CD4 - cre cells in a dose dependent manner, and this was significantly reduced in CbfbF / F CD4 - cre cells.	"TGF - beta	0	10	Protein"	"Foxp3	19	24	Protein"	"CbfbF	28	33	Protein"	"CD4 - cre	38	47	Protein"	"CbfbF	120	125	Protein"	"CD4 - cre	130	139	Protein"	"[{""token"": ""TGF - beta"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Protein""}]"
Control CbfbF / F or CbfbF / F CD4 - cre naive T cells, harboring a Foxp3 - IRES - GFP allele were adoptively transferred into Rag2 - / - mice.	"CbfbF	8	13	Protein"	"CbfbF	21	26	Protein"	"CD4 - cre	31	40	Protein"	"Foxp3	68	73	Protein"	"GFP	83	86	Protein"	"Rag2	127	131	Protein"	"[{""token"": ""CbfbF"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""GFP"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""Rag2"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Protein""}]"
CbfbF / + CD4 - cre CD4 + T cells activated in the presence of TGF - beta showed a clear suppression of T cell proliferation that became even more apparent when an increased ratio of FOXP3 + / CD25 - cells was used ( Fig. 6 B).	"CbfbF	0	5	Protein"	"CD4 - cre	10	19	Protein"	"CD4	20	23	Protein"	"TGF - beta	63	73	Protein"	"FOXP3	183	188	Protein"	"CD25	193	197	Protein"	"[{""token"": ""CbfbF"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Protein""}]"
TGF - beta mediates RUNX induction and FOXP3 is efficiently up - regulated by RUNX1 and RUNX3 in human CD4 + T cells.	"TGF - beta	0	10	Protein"	"RUNX	20	24	Protein"	"FOXP3	39	44	Protein"	"RUNX1	78	83	Protein"	"RUNX3	88	93	Protein"	"CD4	103	106	Protein"	"[{""token"": ""TGF - beta"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""RUNX"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Protein""}]"
As an additional support for this concept, the overexpression of RUNX1 induced increased FOXP3 protein expression without any requirement of TGF - beta and anti - CD3 and anti - CD28 stimulation in human primary CD4 + cells.	"RUNX1	65	70	Protein"	"FOXP3	89	94	Protein"	"TGF - beta	141	151	Protein"	"CD3	163	166	Protein"	"CD28	178	182	Protein"	"CD4	212	215	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Protein""}, {""token"": ""CD28"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Protein""}]"
Whether the diminished capacity of Cbfb - deficient CD4 - cre T cells in the generation of Foxp3 may be caused by peripheral expansion of Cbfb - deficient non - T reg cells or survival problems faced by Cbfb - deficient iT reg cells after Foxp3 induction remains to be elucidated.	"Cbfb	35	39	Protein"	"CD4 - cre	52	61	Protein"	"Foxp3	91	96	Protein"	"Cbfb	138	142	Protein"	"Cbfb	203	207	Protein"	"Foxp3	239	244	Protein"	"[{""token"": ""Cbfb"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Cbfb"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""Cbfb"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Protein""}]"
S2 shows decreased RUNX1 and RUNX3 mRNA and protein expression after siRNA - mediated knockdown and decreased FOXP3 expression in human CD4 + T cells after RUNX1 and RUNX3 knockdown.	"RUNX1	19	24	Protein"	"RUNX3	29	34	Protein"	"FOXP3	110	115	Protein"	"CD4	136	139	Protein"	"RUNX1	156	161	Protein"	"RUNX3	166	171	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Protein""}]"
S7 shows similar cell death ( A) and proliferation ( B) of Foxp3 + and Foxp3 - cells in CbfbF / F CD4 - cre and CbfbF / F control mice cultures.	"Foxp3	59	64	Protein"	"Foxp3	71	76	Protein"	"CbfbF	88	93	Protein"	"CD4	98	101	Protein"	"cre	104	107	Protein"	"CbfbF	112	117	Protein"	"[{""token"": ""Foxp3"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""cre"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""CbfbF"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Protein""}]"
RUNX1 and RUNX3 expression in Foxp3 + T reg cells and in human CD4 +, CD127 -, CD25high cells.	"RUNX1	0	5	Protein"	"RUNX3	10	15	Protein"	"Foxp3	30	35	Protein"	"CD4	63	66	Protein"	"CD127	70	75	Protein"	"CD25high	79	87	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""CD25high"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Protein""}]"
( B) Human primary CD4 + cells were transfected with an empty vector ( pGL3 Basic), a vector containing the putative FOXP3 promoter region ( FOXP3 - 511 / + 176) fused to the luciferase reporter gene, or with a vector containing the putative FOXP3 promoter region ( FOXP3 - 511 / + 176) with single RUNX binding sites mutated ( 53, 287, or 333) or with the combination of two or three RUNX binding sites mutated ( 53, 287, or 333) fused to the luciferase reporter gene.	"CD4	19	22	Protein"	"FOXP3	117	122	Protein"	"FOXP3	141	146	Protein"	"luciferase	175	185	Protein"	"FOXP3	242	247	Protein"	"luciferase	444	454	Protein"	"[{""token"": ""CD4"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Protein""}, {""token"": ""luciferase"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 242, ""end_span"": 247, ""type"": ""Protein""}, {""token"": ""luciferase"", ""start_span"": 444, ""end_span"": 454, ""type"": ""Protein""}]"
( B) Naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele) were adoptively transferred into Rag - deficient mice ( 5 x 106 cells per transfer).	"CD4	11	14	Protein"	"Cbfb	30	34	Protein"	"CD4 - cre	35	44	Protein"	"Foxp3	75	80	Protein"	"GFP	90	93	Protein"	"Rag	135	138	Protein"	"[{""token"": ""CD4"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Protein""}, {""token"": ""Cbfb"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""CD4 - cre"", ""start_span"": 35, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""GFP"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""Rag"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Protein""}]"
The best - known mammalian NF - kappaB subunits are Rel proteins, including RelA ( p65), RelB, c - Rel, p50, and p52 ( refs. 4, 5).	"RelA	76	80	Protein"	"p65	83	86	Protein"	"RelB	89	93	Protein"	"c - Rel	95	102	Protein"	"p50	104	107	Protein"	"p52	113	116	Protein"	"[{""token"": ""RelA"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Protein""}]"
Given that RPS3 can be found in the cytoplasmic p65 - p50 - IkappaBalpha inhibitory complex in resting cells6, we hypothesized that activated IKKbeta might also bind to and phosphorylate RPS3.	"RPS3	11	15	Protein"	"p65	48	51	Protein"	"p50	54	57	Protein"	"IkappaBalpha	60	72	Protein"	"IKKbeta	142	149	Protein"	"RPS3	187	191	Protein"	"[{""token"": ""RPS3"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""IkappaBalpha"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Protein""}]"
To examine whether the RPS3 - IKKbeta interaction is required for RPS3 nuclear translocation, we knocked down IKKalpha or IKKbeta expression with siRNAs ( Supplementary Fig. 1) and then observed stimulation - induced RPS3 nuclear migration by confocal microscopy.	"RPS3	23	27	Protein"	"IKKbeta	30	37	Protein"	"RPS3	66	70	Protein"	"IKKalpha	110	118	Protein"	"IKKbeta	122	129	Protein"	"RPS3	217	221	Protein"	"[{""token"": ""RPS3"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Protein""}, {""token"": ""IKKalpha"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Protein""}]"
Interleukin 8 ( IL - 8) secretion induced by either T cell receptor ( TCR) agonist stimulation or PMA + I was decreased as a consequence of reduced RPS3 / p65 recruitment to the IL8 kappaB sites in the presence of S209A mutant compared to wild - type RPS3 ( Supplementary Fig. 10).	"Interleukin 8	0	13	Protein"	"IL - 8	16	22	Protein"	"RPS3	148	152	Protein"	"p65	155	158	Protein"	"IL8	178	181	Protein"	"RPS3	251	255	Protein"	"[{""token"": ""Interleukin 8"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""IL - 8"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Protein""}, {""token"": ""IL8"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 251, ""end_span"": 255, ""type"": ""Protein""}]"
To determine if NleH1 inhibits RPS3 phosphorylation, we infected HeLa cells with E. coli O157: H7 strains possessing or lacking either nleH1 ( deltanleH1) or with a strain lacking a functional T3SS unable to inject NleH1 into mammalian cells ( deltaescN).	"NleH1	16	21	Protein"	"RPS3	31	35	Protein"	"nleH1	135	140	Protein"	"deltanleH1	143	153	Protein"	"NleH1	215	220	Protein"	"deltaescN	244	253	Protein"	"[{""token"": ""NleH1"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""nleH1"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Protein""}, {""token"": ""deltanleH1"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""NleH1"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Protein""}, {""token"": ""deltaescN"", ""start_span"": 244, ""end_span"": 253, ""type"": ""Protein""}]"
Our discovery that NleH1 inhibits RPS3 S209 phosphorylation suggested that it should also blocks RPS3 - dependent NF - kappaB target gene transcription ( e. g. IL8, NFKBIA, and TNFAIP3).	"NleH1	19	24	Protein"	"RPS3	34	38	Protein"	"RPS3	97	101	Protein"	"IL8	160	163	Protein"	"NFKBIA	165	171	Protein"	"TNFAIP3	177	184	Protein"	"[{""token"": ""NleH1"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Protein""}, {""token"": ""IL8"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""NFKBIA"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Protein""}, {""token"": ""TNFAIP3"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Protein""}]"
To explore the mechanism by which NleH1 inhibits RPS3 S209 phosphorylation, we first performed an in vitro kinase assay with purified wild - type His - NleH1 protein and a mutant His - NleH1 ( K159A) protein, confirming that NleH1 is autophosphorylated and the K159A is an NleH1 kinase - dead mutant ( Fig. 7a).	"NleH1	34	39	Protein"	"RPS3	49	53	Protein"	"His - NleH1	146	157	Protein"	"His - NleH1	179	190	Protein"	"NleH1	225	230	Protein"	"NleH1	273	278	Protein"	"[{""token"": ""NleH1"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""His - NleH1"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""His - NleH1"", ""start_span"": 179, ""end_span"": 190, ""type"": ""Protein""}, {""token"": ""NleH1"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Protein""}, {""token"": ""NleH1"", ""start_span"": 273, ""end_span"": 278, ""type"": ""Protein""}]"
Preincubation of IKKbeta with NleH1 reduced IKKbeta - mediated RPS3 phosphorylation, i. e. the CK2 kinase specificity, but not IKKbeta - mediated GST - IkappaBalpha phosphorylation, i. e. the IKK kinase specificity ( Fig. 7e).	"IKKbeta	17	24	Protein"	"NleH1	30	35	Protein"	"IKKbeta	44	51	Protein"	"RPS3	63	67	Protein"	"IKKbeta	127	134	Protein"	"GST - IkappaBalpha	146	164	Protein"	"[{""token"": ""IKKbeta"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""NleH1"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""RPS3"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""IKKbeta"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Protein""}, {""token"": ""GST - IkappaBalpha"", ""start_span"": 146, ""end_span"": 164, ""type"": ""Protein""}]"
The NF - kappaB family includes RelA / p65, c - Rel, RelB, p50 and p52 that share a highly conserved 300 - amino acid Rel homology domain ( RHD) for homo - or hetero - dimerization and DNA - binding.	"RelA	32	36	Protein"	"p65	39	42	Protein"	"c - Rel	44	51	Protein"	"RelB	53	57	Protein"	"p50	59	62	Protein"	"p52	67	70	Protein"	"[{""token"": ""RelA"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""c - Rel"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Protein""}, {""token"": ""RelB"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""p52"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Protein""}]"
Real - time PCR of CSF3, LTA, NFKBIA, TLR2, GAPDH and ACTB was performed using the RT2 profiler PCR Array - Human NF - kappaB signaling pathway ( QIAGEN Sciences, MD, USA).	"CSF3	19	23	Protein"	"LTA	25	28	Protein"	"NFKBIA	30	36	Protein"	"TLR2	38	42	Protein"	"GAPDH	44	49	Protein"	"ACTB	54	58	Protein"	"[{""token"": ""CSF3"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""LTA"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""NFKBIA"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""TLR2"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""GAPDH"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""ACTB"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Protein""}]"
Transient stimulation with PMA increased the NF - kappaB DNA binding activity and nuclear p65 at 5 min peaking at 60 - 120 min independently of the presence of Tat ( Figure 2A and B); however, while the p65 DNA binding and nuclear p65 persisted elevated at 240 - min post - treatment in Tat - positive cells, they dropped in Tat - negative cells ( Figure 2A and B).	"p65	90	93	Protein"	"Tat	160	163	Protein"	"p65	203	206	Protein"	"p65	231	234	Protein"	"Tat	287	290	Protein"	"Tat	325	328	Protein"	"[{""token"": ""p65"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 287, ""end_span"": 290, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 325, ""end_span"": 328, ""type"": ""Protein""}]"
Next, we evaluated whether Tat counteracted the IkappaB - alpha - mediated inhibition of p65 binding to DNA by incubating in vitro translated p65 and IkappaB - alpha proteins with the NF - kappaB probe in presence or absence of Tat followed by EMSA.	"Tat	27	30	Protein"	"IkappaB - alpha	48	63	Protein"	"p65	89	92	Protein"	"p65	142	145	Protein"	"IkappaB - alpha	150	165	Protein"	"Tat	228	231	Protein"	"[{""token"": ""Tat"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 48, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Protein""}]"
Tat significantly increased the expression of MIP - 1alpha, CSF3, LTA, NFKBIA and TLR2, while the mutants Tat C ( 22, 25, 27) A and Tat R ( 49 - 57) A were ineffective ( Figure 5A - E).	"Tat	0	3	Protein"	"MIP - 1alpha	46	58	Protein"	"CSF3	60	64	Protein"	"LTA	66	69	Protein"	"NFKBIA	71	77	Protein"	"TLR2	82	86	Protein"	"[{""token"": ""Tat"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""CSF3"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Protein""}, {""token"": ""LTA"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""NFKBIA"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""TLR2"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Protein""}]"
By ChIP, Tat bound to the NF - kappaB - responsive promoters, and not to the GAPDH and ACTB promoters, with loss of binding following p65 RNA interference ( Figure 5I), suggesting that Tat occupancy occurred via p65 interaction.	"Tat	9	12	Protein"	"GAPDH	77	82	Protein"	"ACTB	87	91	Protein"	"p65	134	137	Protein"	"Tat	185	188	Protein"	"p65	212	215	Protein"	"[{""token"": ""Tat"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Protein""}, {""token"": ""GAPDH"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Protein""}, {""token"": ""ACTB"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Protein""}]"
As additional findings, IkappaB - alpha was chromatin - immunoprecipitated at the NF - kappaB enhancers in absence of Tat, and it was significantly removed in presence of Tat, or following IkappaB - alpha RNA interference ( Figure 5J), indicating that Tat displaced IkappaB - alpha from promoters.	"IkappaB - alpha	24	39	Protein"	"Tat	118	121	Protein"	"Tat	171	174	Protein"	"IkappaB - alpha	189	204	Protein"	"Tat	252	255	Protein"	"IkappaB - alpha	266	281	Protein"	"[{""token"": ""IkappaB - alpha"", ""start_span"": 24, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 189, ""end_span"": 204, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 266, ""end_span"": 281, ""type"": ""Protein""}]"
Based on the evidence that Tat enhanced the transcriptional activity of the p65 subunit of NF - kappaB ( 49, 63, 64), and physically interacted with the IkappaB - alpha repressor ( 50, 51), we investigated the possibility that Tat could activate NF - kappaB via direct interaction with IkappaB - alpha and p65.	"Tat	27	30	Protein"	"p65	76	79	Protein"	"IkappaB - alpha	153	168	Protein"	"Tat	227	230	Protein"	"IkappaB - alpha	286	301	Protein"	"p65	306	309	Protein"	"[{""token"": ""Tat"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 286, ""end_span"": 301, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 306, ""end_span"": 309, ""type"": ""Protein""}]"
As additional mechanism of NF - kappaB activation, Tat associated with p65 and increased the p65 binding affinity to the NF - kappaB enhancer; this evidence was obtained with recombinant proteins indicating that the stronger binding of p65 to DNA was a consequence of direct association with Tat, which likely caused a conformational change of p65.	"Tat	51	54	Protein"	"p65	71	74	Protein"	"p65	93	96	Protein"	"p65	236	239	Protein"	"Tat	292	295	Protein"	"p65	344	347	Protein"	"[{""token"": ""Tat"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 236, ""end_span"": 239, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 292, ""end_span"": 295, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 344, ""end_span"": 347, ""type"": ""Protein""}]"
